Literature DB >> 20169295

Platelet-derived growth factor receptor alpha gene mutations in vitiligo vulgaris.

Shengxin Xu1, Youwen Zhou, Sen Yang, Yunqing Ren, Chi Zhang, Cheng Quan, Min Gao, Caifeng He, Hui Chen, Jianwen Hhan, Jianjun Chen, Yanhua Liang, Jianqiang Yang, Liangdan Sun, Xianyong Yin, Jianjun Liu, Xuejun Zhang.   

Abstract

Vitiligo vulgaris is an acquired depigmenting disorder resulting from the loss of melanocytes in the skin. Though several putative susceptibility loci of vitiligo have been identified in different populations, the pathogenesis of the disease remains poorly understood. Through genetic linkage analysis of a large Chinese family cohort of vitiligo, we identified a vitiligo linkage locus AIS4 within chromosome 4q12-q21, a region containing several possible candidate genes, including the platelet-derived growth factor receptor alpha (PDGFRA) gene. We postulated that PDGFR mutations may be linked with vitiligo. To test this hypothesis, we performed DNA sequencing on this gene in 143 multiplex families with familial vitiligo vulgaris, 480 patients with sporadic vitiligo vulgaris, and 480 healthy subjects. Mutations were found in 3.5% of familial vitiligo cases, which is significantly higher than for the general population (0.42%, p = 0.008, Fisher's exact test), and possibly higher than in sporadic vitiligo patients (1.0%, p = 0.053). To our knowledge, this is the first observation that PDGFRA mutations are linked with familial vitiligo vulgaris.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20169295     DOI: 10.2340/00015555-0820

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  8 in total

Review 1.  Genetics of Vitiligo.

Authors:  Richard A Spritz; Genevieve H L Andersen
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

2.  Update on the genetics characterization of vitiligo.

Authors:  Hani A Al-Shobaili
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

3.  CD154 blockade abrogates allospecific responses and enhances CD4(+) regulatory T-cells in mouse orthotopic lung transplant.

Authors:  J M Dodd-o; E A Lendermon; H L Miller; Q Zhong; E R John; W M Jungraithmayr; F R D'Alessio; J F McDyer
Journal:  Am J Transplant       Date:  2011-08-09       Impact factor: 8.086

4.  Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP.

Authors:  Stanca A Birlea; Ying Jin; Dorothy C Bennett; Deborah M Herbstman; Margaret R Wallace; Wayne T McCormack; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Mauro Picardo; Giovanni Leone; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Nanja van Geel; Jo Lambert; Andreas Overbeck; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2010-11-18       Impact factor: 8.551

Review 5.  Modern vitiligo genetics sheds new light on an ancient disease.

Authors:  Richard A Spritz
Journal:  J Dermatol       Date:  2013-05       Impact factor: 4.005

6.  Using regulatory and epistatic networks to extend the findings of a genome scan: identifying the gene drivers of pigmentation in merino sheep.

Authors:  Elsa García-Gámez; Antonio Reverter; Vicki Whan; Sean M McWilliam; Juan José Arranz; James Kijas
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

7.  Vitiligo Skin Biomarkers Associated With Favorable Therapeutic Response.

Authors:  Qianli Yang; Guohong Zhang; Mingwan Su; Gigi Leung; Harvey Lui; Pingyu Zhou; Yan Wu; Joshua Zhou; Jinhua Xu; Xuejun Zhang; Youwen Zhou
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

8.  Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin.

Authors:  Richard Yu; Raewyn Broady; Yuanshen Huang; Yang Wang; Jie Yu; Min Gao; Megan Levings; Shencai Wei; Shengquan Zhang; Aie Xu; Mingwan Su; Jan Dutz; Xuejun Zhang; Youwen Zhou
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.